SCHEMBL30678372

SCHEMBL30678372

COc1ccc(CN(Cc2ccc(OC)cc2)c2ncnn3c(C(=O)Nc4cc([N+](=O)[O-])ccc4C)cnc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ MAPT P10636 5/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ HTT P42858 4/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CRHBP P24387 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30678373 0.87 HDAC1 (0.40) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL30678368 0.84 PDE1B (0.36) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL30678371 0.76 PDE1B (0.42) NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL7237063 0.70 HTT (0.76) NPC1RAB9ACYP3A4CYP2D6MAPT
SCHEMBL19354353 0.68 PDE1B (0.44) NPC1RAB9AMAPTALDH1A1KMT2A
SCHEMBL25227436 0.66 KMT2A (0.49) NPC1RAB9AMAPTALDH1A1KMT2A
SCHEMBL30473818 0.66 KMT2A (0.49) NPC1RAB9AMAPTALDH1A1KMT2A
SCHEMBL29921576 0.66 PDE1B (0.41) NPC1RAB9AMAPTALDH1A1KMT2A
SCHEMBL29873266 0.65 MAPT (0.45) NPC1RAB9AMAPTKMT2AMEN1
SCHEMBL19354355 0.64 PDE1B (0.39) NPC1RAB9AMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117126140-A Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same 四川科伦博泰生物医药股份有限公司 2023-11-28 — — CN disclosed
Send feedback